Adenosine is a key immunosuppressive metabolite in the tumor microenvironment (91), and Treg cells isolated from peripheral blood of GC patients have the ability to promote adenosine production, which in turn inhibits the activity of CD8+ T cells through the A2aR pathway (92). Here, CD8A is linked to neoplasm.